Gastroenterology Doctors in Portsmouth, OH Accepting Medicare

2 Gastroenterology doctors found. Showing 1 - 2

Jesse P Houghton, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1711 27th St Ste 403, Portsmouth, OH 45662 Phone: 740-356-6828    Fax: 740-356-6820

Dr. Charles Chu-li Wong, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1729 Kinneys Lane, Suite 203, Portsmouth, OH 45662 Phone: 740-354-2942    Fax: 740-353-3661

News Archive

SQUIRE phase III study shows necitumumab improves median overall survival in squamous NSCLC patients

This week, Lancet Oncology reports results of a 1,093-person phase III clinical trial of the drug necitumumab (IMC-11F8) combined with chemotherapies gemcitabine and cisplatin against stage IV squamous non-small cell lung cancer. With addition of necitumumab, median overall survival was 11.5 months compared with median survival of 9.9 months with the two chemotherapies alone.

Integra Holdings, a biopharmaceutical holding company, announced by Yissum

Yissum Research and Development Company of the Hebrew University of Jerusalem, the technology transfer company of the Hebrew University, announced today the inception of its subsidiary, Integra Holdings, a holding company focusing on biopharmaceutical companies based on inventions of researchers from the Hebrew University.

Patients with RBD sleep disorder have risk of developing Parkinson's disease in future

Researchers from Aarhus University have discovered that patients with the RBD sleep behavior disorder lack dopamine and have a form of inflammation of the brain. This means that they are at risk of developing Parkinson's disease or dementia when they grow older.

MEDICA CONNECTED HEALTHCARE FORUM will continue being a programme highlight at the MEDICA IT area

After its widely acclaimed debut and high level of public appeal within the scope of the MEDICA 2014, the MEDICA CONNECTED HEALTHCARE FORUM is going to be continued this year and is going to remain an important highlight within the programme of the world's largest medical trade fair, MEDICA, which most recently had around 4,800 exhibitors and almost 130,000 specialist visitors.

FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency

Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.

Read more Medical News

› Verified 7 days ago